Nexium ad for Canadian HCPs
Thank you doctor!
See what can happen. Nexium
Esomeprazole Esomeprazole is a proton pump inhibitor (brand names Sompraz, Zoleri, Nexium, Lucen, Esopral; Axagon in Italy, Nexiam in Belgium) developed and marketed by AstraZeneca which is used in the treatment of dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (GORD/GERD) and Zollinger-Ellison syndrome. Esomeprazole is the S-enantiomer of omeprazole (marketed as Losec/Prilosec), and AstraZeneca claims improved efficacy of this single enantiomer product over the racemic mixture of omeprazole. However, this greater efficacy has been disputed, with some claiming it offers no benefit from its older form. (see below). Esomeprazole was the third biggest selling pharmaceutical drug in the world for 2005, totaling US$ 5.7 billion in sales.
Brand name: Nexium
Generic name/category: Esomeprazole
Company: AstraZeneca
Country/Market: Canada
Indication(s)/use: reduction of gastric acid, reflux esophagitis, heartburn, etc
Target: Healthcare Professionals (HCP)
Tagline: See what can happen
Publication: The Journal of Gastroenterology May 2009




